Two great men join the pSivida board of directors
The respective chairmen of leading international companies Alseres Pharmaceuticals and Aderis Pharmaceuticals have been welcomed onto the board of directors at drug delivery company pSivida board of directors.
The respective chairmen of leading international companies Alseres Pharmaceuticals and Aderis Pharmaceuticals have been welcomed onto the board of directors at drug delivery company pSivida board of directors.
Peter Savas of Alseres Pharmaceuticals and Paul Hopper Aderis Pharmaceuticals, both of whom are chief executive officers of their respective companies and have a track record of success in building successful biotech firms, take up their positions as non-executive members.
Savas has experience in the clinical development of biopharmaceutical products for the diagnosis of degenerative neurological diseases and the treatment of acute spinal cord injury. Meanwhile, Hopper is the founder and lead director of Polynoma LLC and was managing director of
Australian Cancer Technology Limited (ACU), which was rated by CitiGroup as one of the best performing biotechs in the Australian index in 2004. pSivida is headquartered in Watertown, Massachusetts.